文献速递糖尿病

外分泌胰腺糖尿病的特征与临床病程:一项全国性人群队列研究

Characteristics and Clinical Course of Diabetes of the Exocrine Pancreas: A Nationwide Population-Based Cohort Study.
PubMed 文献 · Diabetes Care · 2022-01-01

该研究基于韩国国民健康保险服务健康筛查队列(2012–2017年),将糖尿病患者分为无胰腺疾病史的2型糖尿病组(n=153,894)和有胰腺疾病史的外分泌胰腺糖尿病(DEP)组(n=3,629),比较两组胰岛素启用、糖尿病并发症和死亡风险。结果显示DEP组胰岛素使用风险更高(5年调整HR 1.38,95%CI 1.30–1.47,P<0.0001),低血糖、微血管和大血管并发症及全因死亡风险均高于2型糖尿病组。

要点

  • DEP患者5年胰岛素启用风险高于2型糖尿病(调整HR 1.38,95%CI 1.30–1.47)。
  • DEP患者低血糖、神经病变、肾病、视网膜病变、冠心病、脑血管病及外周动脉疾病风险均高于2型糖尿病。
  • DEP患者全因死亡风险高于2型糖尿病(OR 1.74,95%CI 1.57–1.93)。

核心结论

  • DEP比2型糖尿病更可能需要胰岛素治疗。
  • DEP患者低血糖、微血管和大血管并发症及全因死亡事件均高于2型糖尿病。

研究设计与样本

  • 基于韩国国民健康保险服务健康筛查队列(2012–2017年)的全国性人群队列研究。
  • 将糖尿病患者分为无既往胰腺疾病的2型糖尿病组(n=153,894)和有既往胰腺疾病诊断的DEP组(n=3,629)。
  • 使用ICD-10编码和药房处方信息定义2型糖尿病、DEP及急慢性糖尿病并发症。
  • 采用Kaplan-Meier曲线比较两组随时间变化的胰岛素使用情况,并建立logistic回归模型分析糖尿病并发症进展和死亡的比值比。

主要发现

  • DEP组与2型糖尿病组相比,5年胰岛素使用调整风险比HR为1.38(95%CI 1.30–1.47),P<0.0001。
  • DEP组低血糖风险OR为1.85(95%CI 1.54–2.21),P<0.0001;糖尿病神经病变OR为1.38(95%CI 1.28–1.49),P<0.0001;肾病OR为1.38(95%CI 1.27–1.50),P<0.0001;视网膜病变OR为1.10(95%CI 1.01–1.20),P=0.0347。
  • DEP组冠心病OR为1.59(95%CI 1.48–1.70),P<0.0001;脑血管病OR为1.38(95%CI 1.28–1.49),P<0.0001;外周动脉疾病OR为1.34(95%CI 1.25–1.44),P<0.0001。
  • DEP组全因死亡OR为1.74(95%CI 1.57–1.93),P<0.0001,高于2型糖尿病组。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The natural course of diabetes of the exocrine pancreas (DEP) is not well established. We aimed to compare the risk of insulin initiation, diabetic complications, and mortality between DEP and type 2 diabetes. RESEARCH DESIGN AND METHODS: Using the Korean National Health Insurance Service-Health Screening Cohort between 2012 and 2017, we divided patients with diabetes into those with diabetes without prior pancreatic disease (indicated type 2 diabetes, n = 153,894) and diabetes with a prior diagnosis of pancreatic disease (indicated DEP, n = 3,629). ICD-10 codes and pharmacy prescription information were used to define type 2 diabetes, DEP, and acute and chronic diabetes complications. Kaplan-Meier curves were produced to compare insulin use over time between groups. We created logistic regression models for odds of progression to diabetic complications and mortality. RESULTS: DEP was associated with a higher risk of insulin use than type 2 diabetes (adjusted hazard ratio 1.38 at 5 years [95% CI 1.30-1.47], P < 0.0001). Individuals with DEP showed higher risks of hypoglycemia (odds ratio 1.85 [1.54-2.21], P < 0.0001), diabetic neuropathy (1.38 [1.28-1.49], P < 0.0001), nephropathy (1.38 [1.27-1.50], P < 0.0001), retinopathy (1.10 [1.01-1.20], P = 0.0347), coronary heart disease (1.59 [1.48-1.70], P < 0.0001), cerebrovascular disease (1.38 [1.28-1.49], P < 0.0001), and peripheral arterial disease (1.34 [1.25-1.44], P < 0.0001). All-cause mortality was higher in those with DEP (1.74 [1.57-1.93], P < 0.0001) than in those with type 2 diabetes. CONCLUSIONS: DEP is more likely to require insulin therapy than type 2 diabetes. Hypoglycemia, micro- and macrovascular complications, and all-cause mortality events are higher in DEP compared with type 2 diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Lee N, Park SJ, Kang D, et al. Characteristics and Clinical Course of Diabetes of the Exocrine Pancreas: A Nationwide Population-Based Cohort Study. Diabetes Care. 2022. PMID: 35226735. doi:10.2337/dc21-1659

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。